-+ 0.00%
-+ 0.00%
-+ 0.00%
AstraZeneca, Tempus AI Extend Master Services Agreement
Share
Listen to the news
10:50 AM EST, 11/18/2026 (MT Newswires) -- AstraZeneca (AZN.L, AZN.ST) and Tempus AI (F3M.F) agreed to extend their master services agreement by an additional five years, starting from Jan. 1, 2027, to Dec. 31, 2031. Under the fifth amendment to the agreement dated November 2021, the British drugmaker pledged $200 million in fees payable to the US healthcare technology company, according to a Wednesday filing. AstraZeneca also committed to a minimum of $32 million in fees in each calendar year during the renewal period. The contract may be extended until Dec. 31, 2032, if the pledged amount is not met at the end of the period. AstraZeneca is also obliged to pay any shortfall if it decides to terminate the deal earlier.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending